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Abstract Both insulin and muscle contraction stimulate glucose
transport activity. However, contraction stimulation does not
involve the insulin signalling intermediate phosphatidylinositol 3-
kinase (PI 3-kinase). Protein kinase B (PKB) has recently been
identified as a direct downstream target of PI 3-kinase in the
insulin signalling pathway. We have examined here whether the
two stimuli share PKB as a convergent step in separate signalling
pathways. Insulin stimulates both glucose transport, GLUT4
cell-surface content and PKB activity (by 4^6-fold above basal)
in a wortmannin-sensitive manner in in vitro incubated rat soleus
muscles. By contrast, muscle contraction, which stimulates
glucose transport and the cell surface content of GLUT4 by 3-
fold above basal levels, had no effect on PKB activity. These data
demonstrate that PKB is not a mediator of contraction-induced
glucose transport and GLUT4 translocation.
z 1998 Federation of European Biochemical Societies.
Key words: Protein kinase B; Skeletal muscle; Contraction
signalling; 2-N-4-(1-Azi-2,2,2-tri£uoroethyl)benzoyl-
1,3-bis-(D-mannos-4-yloxy)-2-propylamine; GLUT4
1. Introduction
Transport of glucose across the surface membrane of
muscle cells is the cardinal step in glucose disposal. Both in-
sulin and contraction stimulate glucose transport in skeletal
muscles by increasing the cell surface GLUT4 content. Insulin
stimulates glucose transport through a pathway that involves
binding to a speci¢c receptor at the cell surface followed by
activation of the receptor’s intrinsic tyrosine kinase activity.
The activated insulin receptor then phosphorylates down-
stream proteins, including insulin receptor substrates (IRS-
1^4). The p85 regulatory subunit of phosphatidylinositol 3-
kinase (PI 3-kinase) binds to the activated IRS and thereby
activates the lipid kinase of the p110 catalytic subunit. Acti-
vation of PI 3-kinase leads to generation of 3-phosphorylated
phosphoinositides such as phosphatidylinositol 3,4-bisphos-
phate and phosphatidylinositol 3,4,5-triphosphate, which act
as second messengers (for reviews see [1,2]). By contrast to the
insulin-mediated processes, little is known about intracellular
signalling mechanisms through which muscle contraction elic-
its glucose transport and GLUT4 translocation. It has been
demonstrated that muscle contraction has no e¡ect on tyro-
sine phosphorylation of either the insulin receptor or IRS-1
[3]. Furthermore, inhibition of PI 3-kinase with the speci¢c
inhibitor wortmannin, which is capable of completely block-
ing insulin action, has no e¡ect on contraction-stimulated
glucose uptake and GLUT4 translocation [4^6]. E¡ects of
insulin and contraction on glucose transport [7^10] and
GLUT4 translocation [4,11] are additive. Although contrac-
tion and insulin both recruit GLUT4 to the plasma membrane
and stimulate glucose transport, the signalling pathways seem
to be distinct. Thus it is conceivable that contraction stimu-
lates glucose transport either via a pathway entirely di¡erent
to that of insulin or through common steps downstream of
the wortmannin-sensitive PI 3-kinase which is stimulated by
insulin.
The serine/threonine kinase PKB (also known as RAC and
Akt) has recently been shown to be a downstream target for
the PI 3-kinase-generated signals [12^15]. This occurs through
activation by the 3-phosphoinositide-dependent kinase (PDK-
1) [16,17]. Over-expression of a constitutive active PKB mu-
tant in 3T3-L1 and rat adipose cells increases glucose trans-
port and promotes GLUT4 translocation [18^20]. This does
not necessarily implicate PKB in the normal insulin-stimu-
lated pathway leading to glucose transport. It is necessary
to show that inhibition of PKB inhibits the insulin stimulus.
In an attempt to address this issue Cong et al. transiently
transfected rat adipose cells with an inhibitory form of
PKB. They reported that this inhibited insulin-stimulated
translocation of GLUT4 by 20% [20]. If insulin and contrac-
tion share a common step downstream of PI 3-kinase, then
PKB may be a candidate for a common mediator of insulin-
and contraction-stimulated glucose transport and GLUT4
translocation in skeletal muscles. For this reason we have ex-
plored the e¡ect of contraction on activation of PKB in rat
skeletal muscles. Our results demonstrate that insulin activates
PKB in a wortmannin-sensitive manner. By contrast, muscle
contraction did not activate PKB. Therefore PKB can be ex-
cluded as a mediator of contraction-induced glucose transport
and GLUT4 translocation.
2. Materials and methods
2.1. Materials
2-N-4-(1-Azi-2,2,2-tri£uoroethyl)benzoyl-1,3-bis-(D-mannos-4-ylox-
y)-2-propylamine (ATB-[2-3H]BMPA, speci¢c activity 10 Ci/mmol)
was prepared as described previously [21]. 3-O-[3H]Methyl-D-glucose
and [14C]D-mannitol were from Du Pont-NEM (UK). Protein A-Se-
pharose CL-4B, protein kinase A inhibitor fragment 6^22 amide,
wortmannin, and bovine serum albumin (radioimmunoassay grade)
were from Sigma (St. Louis, MO, USA). Thesit was from Boehringer
Mannheim (Mannheim, Germany). Insulin was from Novo-Nordisk,
Denmark, anti-akt1 (C-20) a⁄nity-puri¢ed goat polyclonal antibody
from Santa Cruz Biotechnology, Santa Cruz, CA, protein G Sephar-
ose 4 fast £ow from Pharmacia, St. Albans, UK, adenosine
[Q-32P]triphosphate redivue equivalent from Amersham, Little Chal-
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font, UK and P81 cellulose phosphate paper from Whatman, Maid-
stone, UK.
2.2. Insulin and contraction stimulation of in vitro incubated rat soleus
muscles
Male Wistar rats (Mollegaards Breeding Laboratory, Denmark)
weighing 55^65 g were deprived of food overnight, killed by a blow
to the neck followed by cervical dislocation. Soleus muscles were
rapidly but carefully dissected out avoiding stretching of the muscle
¢bres. Intact soleus muscles were incubated initially for 10 min in 4 ml
oxygenated Krebs-Henseleit bicarbonate bu¡er (KHB bu¡er: 1.2 mM
KH2PO4, 25 mM NaHCO3, 118.5 mM NaCl, 4.7 mM KCl, 2.5 mM
CaCl2, 1.2 mM MgSO4, pH 7.4) containing 2 mM pyruvate, 38 mM
mannitol and 0.1% BSA (radioimmunoassay grade). In experiments
with wortmannin, this was added to the bu¡er immediately before
use. Then further incubation took place for 20 min in identical me-
dium in the absence or presence of 1 mU/ml insulin and wortmannin.
Muscles were then used for measurements of either glucose transport
activity, cell surface GLUT4 content or PKB measurements.
The e¡ect of muscle contraction was investigated using a pulse
generator as described previously [4]. Brie£y, soleus muscles were ¢rst
preincubated as described above, then mounted on two platinum elec-
trodes positioned 3 mm apart and surrounding the central part of the
muscle. The mounted muscle was then immersed in 4 ml oxygenated
KHB containing the same constituents as described above for the
preincubation phase. Muscles were stimulated to contract for 5 min
at 10 Hz with square-wave pulses of 0.5 ms duration and 10 V am-
plitude. We have previously found that this contraction protocol pro-
duced maximal e¡ects on glucose transport and GLUT4 translocation
in soleus muscles [4]. Immediately after the contraction period,
muscles were removed and treated as described above for the meas-
urement of glucose transport activity. All incubations were carried out
at 30‡C under continuous gassing with 95% O2, 5% CO2 in a shaking
water bath.
2.3. 3-O-Methylglucose (3-OMG) uptake
Muscles used for assessment of glucose transport activity were in-
cubated in 3 ml KHB containing 8 mM 3-O-[3H]methyl-D-glucose
(437 WCi/mmol) and 32 mM [14C]D-mannitol (8 WCi/mmol) for a
period of 10 min, at 30‡C under continuous gassing (95% O2, 5%
CO2). After the ¢nal incubation muscles were blotted on ¢lter paper
and clamp-frozen in liquid N2. Glucose transport activity was
calculated from the intracellular [3H]3-OMG accumulation using
[U-14C]D-mannitol as the extracellular marker as described previously
[22].
2.4. Photolabelling of rat soleus muscles
Muscles used for assessment of cell surface GLUT4 content were
incubated at 18‡C for 8 min in KHB bu¡er containing 1 mCi/ml
ATB-[3H]BMPA in a dark room. They were then irradiated 2U3
min in a Rayonet RPR 100 photochemical reactor (RPR 3000 lamps).
Muscles were turned over between irradiations to achieve maximum
exposure. Following irradiation, muscles were immediately blotted,
trimmed and clamp-frozen in liquid N2. Photolabelled muscles were
processed for cell surface GLUT4 as described previously [22].
2.5. Protein kinase B measurements in rat soleus muscle
Muscles were homogenised in 1.25 ml bu¡er (10 mM Tris, 5 mM
EDTA, 255 mM sucrose, 10 mM NaF, 0.2 mM Na3VO4, 1 mM
sodium molybdate, 1 Wg/ml antipain, aprotinin, pepstatin, leupeptin
and 100 WM AEBSF, pH 7.2). Triton X-100 was added to the homog-
enates to give a ¢nal concentration of 1% Triton X-100, and samples
were rotated for 30 min at 4‡C. Homogenates were centrifuged at
20 000Ug for 10 min and the soluble fractions were added to anti-
PKB antibody conjugated to protein G sepharose. Immunoprecipi-
tates were rotated for 2 h at 4‡C. The immune pellets were then
washed twice with homogenisation bu¡er (containing 1% Triton X-
100), and then twice with kinase bu¡er (50 mM Tris, 10 mM MgCl2,
pH 7.5). The washed pellets were added to 40 Wl assay bu¡er contain-
ing 50 mM Tris, 10 mM MgCl2, 1 mM DTT, 100 ng PKA inhibitor
peptide, and 25 Wg protamine sulphate pH 7.4. Samples were main-
tained for 5 min at room temperature. The reactions were started by
adding 5 Wl 50 WM ATP and 5 Wl 2 WCi [Q-32P]ATP to each tube. After
20 min at 30‡C, supernatants were removed and 40 Wl of 2% SDS
added to the pellets. After a further 10 min, this supernatant was
removed. The two supernatants were pooled and 20 Wl of the com-
bined supernatants were spotted onto a 2 cmU2 cm area of phospho-
cellulose paper. The phosphocellulose paper was washed ¢ve times
with 500 ml 75 mM phosphoric acid. This was followed by washing
with water and then acetone. After drying, the phosphocellulose paper
was cut into squares and the radioactivity counted by liquid scintilla-
tion counting.
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Fig. 1. A: 3-O-Methylglucose transport in in vitro incubated rat sol-
eus muscles. Muscles were incubated at 30‡C as described in Section
2. Basal: unstimulated muscles; Insulin: incubation with 1 mU/ml
insulin for 20 min; Ins+Wort: muscles were preincubated with 1 WM
wortmannin for 10 min, then stimulated with 1 mU/ml insulin+
1 WM wortmannin for 20 min. Contraction: muscles were preincu-
bated as described in Section 2, then stimulated to contract for
5 min at 10 Hz; Ins+Cont: muscles were incubated with 1 mU/ml
insulin for 20 min, then stimulated to contract for 5 min at 10 Hz.
Values are mean þ S.E.M. (n = 10^18). *Signi¢cantly di¡erent from
insulin, P6 0.001. B: ATB-BMPA labelling of rat soleus muscles.
Cell surface GLUT4 content was determined as described in Section
2. Muscles were stimulated as described in A. Values are mean þ
S.E.M. (n = 5^7). *Signi¢cantly di¡erent from insulin, P6 0.005.
C: Protein kinase B activity in isolated rat soleus muscles. Muscles
were incubated and stimulated as in A. Values are mean þ S.E.M.
(n = 6). *Signi¢cantly di¡erent from basal, P6 0.001.
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3. Results and discussion
3.1. E¡ect of insulin and contraction on glucose transport
activity and cell surface GLUT4 content
As depicted in Fig. 1A,B, insulin at a concentration of
1 mU/ml, which induces a maximal stimulatory e¡ect [22],
resulted in a V6-fold increase above basal levels in both 3-
OMG transport and cell surface GLUT4 content in soleus
muscles. The e¡ects of insulin on glucose transport activity
and cell surface GLUT4 content were completely inhibited by
1 WM of the PI 3-kinase inhibitor wortmannin. Muscle con-
traction accelerated soleus glucose transport activity approx-
imate 3-fold and led to a comparable rise in cell surface
GLUT4 content. As shown previously the maximal stimula-
tory e¡ect of both insulin and muscle contraction was almost
completely additive on glucose transport activity and increase
in cell surface GLUT4 content [4,7^11]. This indicates that at
some level in the signalling pathways, there are di¡erent
mechanisms leading to the stimulatory actions of insulin
and muscle contraction.
3.2. E¡ect of insulin and contraction on protein kinase B
activity
Insulin stimulated PKB activity about 4-fold above basal in
in vitro incubated rat soleus muscles (Fig. 1C) (basal 3.9 þ 0.3
vs insulin 15.2 þ 0.5 Pi incorporated/min/mg muscle). This is
in good agreement with recently published data achieved in
rat skeletal muscles after in vivo insulin administration [23].
The increase correlates well with the fold increase in glucose
transport activity and cell surface GLUT4 content observed
after insulin stimulation (Fig. 1A,B). Addition of 1 WM wort-
mannin, which completely abolished the insulin-induced in-
crease in glucose transport activity and cell surface GLUT4
content, totally prevented the insulin-induced activation of
PKB, indicating, as shown previously [13,14,16,24], that the
regulation of PKB by insulin is mediated by the wortmannin-
sensitive PI 3-kinase. Indeed, wortmannin addition to insulin-
stimulated muscle decreased PKB activity even below basal
activity (basal 3.9 þ 0.3 vs insulin+1 WM wortmannin
0.8 þ 0.1 Pi incorporated/min/mg muscle). However, this is
not re£ected by a similar reduction in glucose transport activ-
ity (basal 1.5 þ 0.2 vs insulin+1 WM wortmannin 1.4 þ 0.2
Wmol/ml/h). One explanation for this e¡ect might be that
basal glucose transport activity is partially stimulated due to
manipulation of the muscles during the surgical procedure
and the in vitro incubation. Additionally, as in 3T3-L1 cells,
long incubations may be required before inhibition of signal-
ling by wortmannin results in a reduced level of basal cell
surface transporters [25]. In contrast to insulin, maximal elec-
trically stimulated muscle contraction, which increased both
glucose transport and cell surface GLUT4 content approxi-
mately 3-fold above basal, did not induce activation of PKB
above basal activity (basal 3.9 þ 0.3 vs contraction 4.2 þ 0.5 Pi
incorporated/min/mg muscle). The combined e¡ect of insulin
and contraction also failed to a¡ect PKB activity further than
that already activated by insulin alone (insulin 15.2 þ 1.2 vs
insulin+contraction 15.6 þ 2.8 Pi incorporated/min/mg
muscle). Our results therefore clearly demonstrate that insu-
lin- and contraction-induced activation pathways do not con-
verge at the level of PKB and that this enzyme is not involved
at all in contraction-induced glucose transport and GLUT4
translocation in rat soleus muscle.
Acknowledgements: This study was supported by grants from the
Medical Research Council (UK), Institute of Experimental Clinical
Research, University of Aarhus, Torben Frimodt og Alice Frimodts
Fond, Else og Mongens Wedell-Wedellsborgs Fond, SÖster og Verner
Lipperts Fond.
References
[1] Holman, G.D. and Kasuga, M. (1997) Diabetologia 40, 991^
1003.
[2] Hemmings, B.A. (1997) Science 275, 628^630.
[3] Goodyear, L.J., Giorgino, F., Balon, T.W., Condorelli, G. and
Smith, R.J. (1995) Am. J. Physiol. 268, E987^95.
[4] Lund, S., Holman, G.D., Schmitz, O. and Pedersen, O. (1995)
Proc. Natl. Acad. Sci. USA 92, 5817^5821.
[5] Yeh, J.I., Gulve, E.A., Rameh, L. and Birnbaum, M.J. (1995)
J. Biol. Chem. 270, 2107^2111.
[6] Lee, A.D., Hansen, P.A. and Holloszy, J.O. (1995) FEBS Lett.
361, 51^54.
[7] Garetto, L.P., Richter, E.A., Goodman, M.N. and Ruderman,
N.B. (1984) Am. J. Physiol. 246, E471^E475.
[8] Nesher, R., Karl, I.E. and Kipnis, D.M. (1985) Am. J. Physiol.
249, C226^C232.
[9] Zorzano, A., Balon, T.W., Goodman, M.N. and Ruderman,
N.B. (1986) Am. J. Physiol. 251, E21^E26.
[10] Wallberg Henriksson, H., Constable, S.H., Young, D.A. and
Holloszy, J.O. (1988) J. Appl. Physiol. 65, 909^913.
[11] Gao, J., Ren, J., Gulve, E.A. and Holloszy, J.O. (1994) J. Appl.
Physiol. 77, 1597^1601.
[12] Franke, T.F., Yang, S.I., Chan, T.O., Datta, K., Kazlauskas, A.,
Morrison, D.K., Kaplan, D.R. and Tsichlis, P.N. (1995) Cell 81,
727^736.
[13] Burgering, B.M. and Co¡er, P.J. (1995) Nature 376, 599^602.
[14] Kohn, A.D., Kovacina, K.S. and Roth, R.A. (1995) EMBO J.
14, 4288^4295.
[15] Cross, D.A.E., Alessi, D.R., Cohen, P., Andjelkovic, M. and
Hemmings, B.A. (1995) Nature 378, 785^789.
[16] Alessi, D.R., James, S.R., Downes, C.P., Holmes, A.B., Ga¡ney,
P.R., Reese, C.B. and Cohen, P. (1997) Curr. Biol. 7, 261^269.
[17] Cohen, P., Alessi, D.R. and Cross, D.A. (1997) FEBS Lett. 410,
3^10.
[18] Kohn, A.D., Summers, S.A., Birnbaum, M.J. and Roth, R.A.
(1996) J. Biol. Chem. 271, 31372^31378.
[19] Tanti, J.F., Grillo, S., Gremeaux, T., Co¡er, P.J., Van Obber-
ghen, E. and Le Marchand Brustel, Y. (1997) Endocrinology 138,
2005^2010.
[20] Cong, L.N., Chen, H., Li, Y., Zhou, L., McGibbon, M.A., Tay-
lor, S.I. and Quon, M.J. (1997) Mol. Endocrinol. 11, 1881^1890.
[21] Clark, A.E. and Holman, G.D. (1990) Biochem. J. 269, 615^622.
[22] Lund, S., Holman, G.D., Schmitz, O. and Pedersen, O. (1993)
FEBS Lett. 330, 312^318.
[23] Cross, D.A.E., Watt, P.W., Morag, S., van der Kaay, J.,
Downes, C.P., Holder, J.C. and Cohen, P. (1997) FEBS Lett.
406, 211^215.
[24] Alessi, D.R., Andjelkovic, M., Caudwell, B., Cron, P., Morrice,
N., Cohen, P. and Hemmings, B.A. (1996) EMBO J. 15, 6541^
6551.
[25] Yang, J., Clarke, J.F., Ester, C.J., Young, P.W., Kasuga, M. and
Holman, G.D. (1996) Biochem. J. 313, 125^131.
FEBS 20060 3-4-98
S. Lund et al./FEBS Letters 425 (1998) 472^474474
